- Home
- CDNA vs VMEO Comparison
CDNA vs VMEO Comparison
Compare CDNA & VMEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- VMEO
- Stock Information
- Founded
- CDNA 1998
- VMEO 2004
- Country
- CDNA United States
- VMEO United States
- Employees
- CDNA N/A
- VMEO N/A
- Industry
- CDNA Medical Specialities
- VMEO Computer Software: Prepackaged Software
- Sector
- CDNA Health Care
- VMEO Technology
- Exchange
- CDNA Nasdaq
- VMEO Nasdaq
- Market Cap
- CDNA 1.1B
- VMEO 1.1B
- IPO Year
- CDNA 2014
- VMEO N/A
- Fundamental
- Price
- CDNA $22.70
- VMEO $6.35
- Analyst Decision
- CDNA Buy
- VMEO Buy
- Analyst Count
- CDNA 8
- VMEO 3
- Target Price
- CDNA $26.43
- VMEO $8.67
- AVG Volume (30 Days)
- CDNA 851.0K
- VMEO 1.4M
- Earning Date
- CDNA 02-26-2025
- VMEO 02-19-2025
- Dividend Yield
- CDNA N/A
- VMEO N/A
- EPS Growth
- CDNA N/A
- VMEO 290.90
- EPS
- CDNA N/A
- VMEO 0.20
- Revenue
- CDNA $312,775,000.00
- VMEO $419,394,000.00
- Revenue This Year
- CDNA $19.85
- VMEO $1.32
- Revenue Next Year
- CDNA $11.34
- VMEO $2.07
- P/E Ratio
- CDNA N/A
- VMEO $32.05
- Revenue Growth
- CDNA 5.26
- VMEO 0.52
- 52 Week Low
- CDNA $7.42
- VMEO $3.43
- 52 Week High
- CDNA $34.84
- VMEO $7.90
- Technical
- Relative Strength Index (RSI)
- CDNA 50.19
- VMEO 46.89
- Support Level
- CDNA $21.09
- VMEO $5.91
- Resistance Level
- CDNA $25.95
- VMEO $6.45
- Average True Range (ATR)
- CDNA 1.67
- VMEO 0.24
- MACD
- CDNA 0.04
- VMEO -0.03
- Stochastic Oscillator
- CDNA 41.96
- VMEO 42.31
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About VMEO Vimeo Inc.
Vimeo Inc is the all-in-one video software solution, providing the full breadth of video tools through a software-as-a-service model. Its comprehensive and cloud-based tools empower its users to create, collaborate and communicate with video on a single, turnkey platform. The company derives its revenue from SaaS subscription fees paid by customers for subscription plans.